SV LIFE Sciences FUND IV Strategic Partners, L. P., 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 149,330 shares at $23.04 ($3.4M) on 2019-03-05, disclosed to the SEC on 2019-03-06.
Open-market sale of $3.4M KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.91 | 1,197 | $27K | 0.8% |
| 2 | $22.91 | 42,181 | $966K | 28.2% |
| 3 | $22.91 | 42,181 | $966K | 28.2% |
| 4 | $23.04 | 893 | $21K | 0.6% |
| 5 | $23.04 | 31,439 | $724K | 21.1% |
| 6 | $23.04 | 31,439 |
| $724K |
| 21.1% |
| Total | $22.97 avg | 149,330 | $3.4M | 100% |
| Filing → |
| OCUL | SELL | 2015-06-11 | $16.4M | — | Filing → |
| OPHT | SELL | 2014-06-05 | $55.8M | — | Filing → |
| TRXC | BUY | 2014-04-23 | $3.0M | — | Filing → |